FRI0566 Teriparatide and alendronate improved bone loss and hyperalgesia in a mouse model of osteoporosis

Published: Jun 1, 2017
Abstract

Background

Osteoporosis may cause not only fractures but also chronic back pain in elderly women. Teriparatide (TPTD) and alendronate (ALN) are widely used in clinical for treatment of osteoporosis. Several studies have demonstrated that TPTD and ALN treatments improved skeletal pain in osteoporosis patients.

Objectives

We investigated the effect of TPTD and ALN on pain-related behavior in ovariectomized (OVX) mice. And we...
Paper Details
Title
FRI0566 Teriparatide and alendronate improved bone loss and hyperalgesia in a mouse model of osteoporosis
Published Date
Jun 1, 2017
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.